GNH USA

Europe — EMA

Momecutan (Mometasone Furoate Ph. Eur.)

GNH USA supplies Momecutan (Mometasone Furoate), a topical glucocorticoid for inflammatory skin conditions. Request a quote for global supply worldwide.

Request sourcing

1
Pack/s

What is Mometasone Furoate Ph. Eur.?

Mometasone furoate, the active ingredient in Momecutan, is a potent corticosteroid presented as a topical formulation for cutaneous application. It exerts anti‑inflammatory and immunosuppressive actions, making it suitable for managing eczema, psoriasis, contact dermatitis and other inflammatory skin disorders in adults and children.

GNH USA supplies Momecutan as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide under strict quality standards and regulatory compliance. Our global distribution network ensures reliable delivery and support for healthcare providers across Europe, Asia, Africa and the Americas.

What is Mometasone Furoate Ph. Eur. used for?

Momecutan (mometasone furoate) is a topical glucocorticoid used to treat inflammatory skin conditions.

- Atopic dermatitis: reduces redness, itching and scaling associated with eczema. - Psoriasis: diminishes plaque formation and inflammation. - Contact dermatitis: alleviates allergic skin reactions and swelling. - Seborrheic dermatitis: controls inflammation and flaking on scalp and face. - Discoid lupus erythematosus: manages cutaneous lesions and local inflammation.

What are the side effects of Mometasone Furoate Ph. Eur.?

Momecutan may cause local skin reactions and, rarely, systemic effects.

Common Side Effects: - Burning or stinging sensation at the application site. - Pruritus or mild itching. - Dryness or peeling of the skin. - Folliculitis or acneiform eruptions. - Erythema or mild redness. - Telangiectasia (visible small blood vessels).

Serious or Rare Side Effects: - Skin atrophy or thinning. - Secondary bacterial, fungal or viral infection. - Hypersensitivity reactions such as urticaria or angioedema. - Systemic adrenal suppression with extensive use. - Delayed wound healing. - Hypertrichosis (excessive hair growth).

What precautions apply to Mometasone Furoate Ph. Eur.?

Before using Momecutan, consider the following safety measures.

- Pregnancy: consult a healthcare professional before use. - Pediatric use: limit duration and surface area in children. - Occlusive dressings: avoid unless directed, as they may increase absorption. - Infected skin: do not apply to areas with bacterial, viral or fungal infection. - Systemic absorption: monitor for signs of adrenal suppression with prolonged use. - Store at room temperature: keep in the original container, protect from moisture and light.

What does Mometasone Furoate Ph. Eur. interact with?

Momecutan can interact with other medications; awareness of these interactions helps minimize risk.

Major Interactions (Avoid):\n- Systemic corticosteroids: may increase risk of systemic glucocorticoid effects. - Potent CYP3A4 inhibitors (e.g., ketoconazole): can raise local drug concentration. - Antifungal or antibacterial topical agents: may enhance percutaneous absorption.

Moderate Interactions (Monitor Closely): - Photosensitizing drugs (e.g., tetracyclines): may increase skin irritation. - Topical retinoids: can exacerbate local irritation. - Anticoagulants: potential for increased skin bruising or delayed healing.

Frequently asked questions

What conditions is Momecutan used to treat?+
Momecutan contains mometasone furoate, a topical glucocorticoid indicated for inflammatory skin disorders such as atopic dermatitis, psoriasis, contact dermatitis, seborrheic dermatitis and certain forms of cutaneous lupus. It helps reduce redness, itching, scaling and swelling associated with these conditions.
How does mometasone furoate work in the skin?+
Mometasone furoate penetrates the skin and binds to intracellular glucocorticoid receptors. The drug‑receptor complex alters gene transcription, suppressing pro‑inflammatory cytokines, inhibiting leukocyte migration, and reducing vasodilation. This results in potent anti‑inflammatory and immunosuppressive effects at the site of application.
What is the usual dose of Momecutan?+
The appropriate dose of Momecutan is determined by the prescribing healthcare professional based on the specific condition, severity, patient age and the area of skin to be treated. Patients should follow the prescriber’s instructions and not exceed the recommended amount.
Is Momecutan safe to use during pregnancy or breastfeeding?+
Safety of topical mometasone furoate during pregnancy or lactation has not been fully established. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Momecutan.
How do I order Momecutan from GNH USA?+
To request Momecutan, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and import documentation.
How does Momecutan compare with other topical steroids?+
Momecutan (mometasone furoate) is a high‑potency corticosteroid, offering stronger anti‑inflammatory activity than low‑potency agents such as hydrocortisone, but it is less potent than very high‑potency steroids like clobetasol propionate. This balance makes it suitable for moderate to severe dermatitis while limiting systemic exposure when used as directed.
What are the storage requirements for Momecutan?+
Momecutan should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and extreme temperatures to maintain its stability and efficacy.
How is Momecutan applied?+
Momecutan is applied topically to the affected skin area. The prescribed amount is gently spread in a thin layer, usually once or twice daily, and gently rubbed in until fully absorbed. Hands should be washed before and after application, and the treated area should not be covered with occlusive dressings unless advised.
What are the most serious risks associated with Momecutan?+
Serious risks include skin atrophy, secondary infections, systemic adrenal suppression with extensive use, and hypersensitivity reactions such as urticaria or angioedema. Patients should report any unusual skin changes, signs of infection or systemic symptoms to their healthcare provider promptly.
Who should not use Momecutan?+
Momecutan should be avoided in individuals with known hypersensitivity to mometasone furoate or any formulation components, in patients with untreated bacterial, viral or fungal skin infections, and in those where systemic corticosteroid therapy is contraindicated. A healthcare professional should evaluate suitability before initiating therapy.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Mometasone Furoate Ph. Eur.
Route
Cutaneous Use
Manufacturer
Mibe Pharmaceuticals D.O.O.
Origin
EU

Related products